State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao.
State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao.
Int J Biol Macromol. 2022 Nov 1;220:1532-1544. doi: 10.1016/j.ijbiomac.2022.09.018. Epub 2022 Sep 9.
Gut microbial β-glucuronidases (GUSs) inhibition is a new approach for managing some diseases and medication therapy. However, the structural and functional complexity of GUSs have posed tremendous challenges to discover specific or broad-spectrum GUSs inhibitors using Escherichia coli GUS (EcoGUS) alone. This study first assessed the effects of twenty-one dietary flavones employing three Loop 1-type GUSs of different taxonomic origins, which were considered to be the main GUSs involved in deglucuronidation of small molecules, on p-nitrophenyl-β-D-glucuronide hydrolysis and a structure-activity relationship is preliminarily proposed based on both in vitro assays and a docking study with representative compounds. EcoGUS and Staphylococcus pasteuri GUS showed largely similar inhibition propensities with potencies positively correlating with the total hydroxyl groups and those at ring B of flavones, while docking results revealed strong interactions developed via ring A and/or C. Streptococcus agalactiae GUS (SagaGUS) exhibited distinct inhibition propensities, displaying late-onset inhibition and steep dose-response profiles with most tested compounds. The α-helix in loop 1 region of SagaGUS which causes spatial hindrance but offers a hydrophobic surface for contacting with the carbonyl group on ring C of flavones is believed to be essential for the allosteric inhibition of SagaGUS. Taken together, the study with a series of flavones revealed varied preferences for GUSs belonging to the same Loop 1-type, highlighting the necessity of adopting multi-GUSs instead of EcoGUS alone for screening broad-spectrum GUSs inhibitors or tailoring the inhibition based on specific GUS structure.
肠道微生物β-葡糖苷酸酶(GUSs)抑制是管理某些疾病和药物治疗的新方法。然而,GUSs 的结构和功能复杂性使得仅使用大肠杆菌 GUS(EcoGUS)发现特异性或广谱 GUSs 抑制剂具有巨大挑战。本研究首次评估了二十一种饮食类黄酮对三种不同分类来源的 Loop 1 型 GUSs 的影响,这三种 GUSs 被认为是参与小分子去糖基化的主要 GUSs,基于体外测定和代表性化合物的对接研究,初步提出了一种结构-活性关系。EcoGUS 和粪肠球菌 GUS 表现出相似的抑制倾向,其效力与类黄酮的总羟基和 B 环上的羟基呈正相关,而对接结果显示出通过 A 环和/或 C 环形成的强相互作用。无乳链球菌 GUS(SagaGUS)表现出明显不同的抑制倾向,表现出迟发性抑制和陡峭的剂量反应曲线,大多数测试化合物均如此。SagaGUS 中 Loop 1 区域的α-螺旋导致空间障碍,但为类黄酮 C 环上的羰基提供了一个疏水表面,被认为对 SagaGUS 的别构抑制至关重要。总之,该系列类黄酮的研究揭示了属于同一 Loop 1 型的 GUSs 存在不同的偏好,这突出了采用多 GUSs 而不是单独使用 EcoGUS 进行广谱 GUSs 抑制剂筛选或根据特定 GUS 结构进行抑制调整的必要性。